The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Sickle Cell Disease Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
BSH 2022 | Challenges in acute and chronic pain management in SCD
Sanne Lugthart, MD, PhD, University Hospitals Bristol NHS Foundation Trust, Bristol, UK, comments on the challenges in acute and chronic pain management in patients with sickle cell disease (SCD). Dr Lugthart explains that it is often not possible to treat patients with SCD who present with acute pain within 30 minutes of arriving to the hospital as recommended in the NICE guidelines. Regarding chronic pain management, it is important to work with special chronic pain and anesthetic teams to deliver the best patient care. This interview took place at the 62nd Annual Scientific Meeting of the British Society for Haematology (BSH) 2022, in Manchester, UK.
Disclosures
Novartis, GBT
